Trial intelligence / Profile preview

Prednisone vs Allopurinol in Heart Failure with Hyperuricemia

NCT00919243Phase 4Completed

Sponsor
Hebei Medical University
Start
Feb 2009
Primary completion
Jul 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of prednisone in heart failure (HF) and hyperuricemia (2 arms), sponsored by Hebei Medical University. Primary endpoint: Change from baseline in uric acid level at 4 weeks. Started Feb 2009; status: completed.

02

Drugs

prednisone
03

Conditions

heart failure (HF)hyperuricemia

Beyond the preview

Go deeper on NCT00919243.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00919243.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call